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bstract
The spore forming bacterium Clostridium perfringens is a widely occurring pathogen. Vaccines against C. perfringens type B
nd C are currently manufactured using -toxin secreted by virulent C. perfringens strains. Large-scale production of vaccines
rom virulent strains requires stringent safety conditions and costly detoxification and control steps. Therefore, it would be
eneficial to produce this toxin in a safe production host and in an immunogenic, but non-toxic form (toxoid). For high-level
xpression of -toxoid, we cloned the highly active ribosomal rpsF promoter of Bacillus subtilis in a broad host range multicopy
lasmid. In B. subtilis, we obtained high intracellular production, up to 200g ml−1 culture. However, the -toxoid was poorly
ecreted. The employed rpsF expression system allowed using the same expression plasmids in other heterologous hosts such
s Lactococcus lactis and Streptococcus pneumoniae. In these organisms secretion of -toxoid was ten times higher compared
o the best producing B. subtilis strain. These results show the usefulness of the rpsF based broad host range expression system.
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. Introduction
Clostridium perfringens is the main cause of
lostridial enteric disease in domesticated animals.
. perfringens types B and C secrete -toxin that
auses necrotic enteritis in cattle, sheep, pigs and goats
Songer, 1996; Springer and Selbitz, 1999). Vaccines
gainst C. perfringens type B and C are currently man-
factured using -toxin produced by the virulent C.
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edium, and the culture medium is harvested and used
or subsequent vaccine development. However, the pro-
uction of vaccines from a virulent strain requires time
onsuming detoxification and control steps and strin-
ent safety conditions. Therefore, it would be beneficial
o produce this toxin in a safe production host, prefer-
bly as a non-toxic variant of the protein, which still
etains full immunogenicity. For high-level expression
nd production it will be necessary to use a strong
romoter, preferably non-artificially induced by costly
nducers. Potential useful promoter candidates are pro-
oters of highly expressed housekeeping genes.
The gene coding for S6 ribosomal protein (rpsF) is
uch a gene. Recently, we have described the regula-
ion of rpsF in Bacillus subtilis. In this bacterium rpsF
orms an operon with ssb and rpsR, encoding single
tranded DNA binding protein and ribosomal protein
18, respectively. In B. subtilis the rpsF promoter is
ighly active during logarithmic growth (Lindner et al.,
004). Since the rpsF promoter controls genes essential
or growth, which are strongly expressed in fast grow-
ng cells, it is likely that this promoter has a growth
ependent control mechanism. We hypothesized that
his particular feature can be utilized when producing
eterologous proteins that are toxic when produced at
igh levels. In theory: when a cell produces a protein
hat causes cell growth to slow down, a cell growth
ependent promoter will slow down the transcription
f the protein cloned behind it, resulting in an equilib-
ium with optimal growth rate and protein production.
nother advantage of the use of a promoter like rpsF is
hat, due to the conserved function of these genes, the
romoter might be active in different bacterial species.
his would enable a quick assessment of production
osts with a single expression construct.
B. subtilis is a promising heterologous host for -
oxoid production. It has an established record for
rotein production and secretion and general safety. B.
ubtilis does not contain endotoxins, has been granted
GRAS status by the FDA, and can secrete proteins
p to 20 g l−1 yields (Harwood, 1992; Schallmey et al.,
004). Furthermore, like C. perfringens, B. subtilis is a
ram-positive organism, which increases the chance of
uccess for production of-toxin. In this study we have
ested the applicability of the rpsF promoter as a high
xpression promoter for -toxin production in B. sub-
ilis. For this purpose we used a variant of the -toxin,
-toxoid, that contains three point mutations render-
f
fi
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ng it no longer toxic, but still immunogenic (Segers et
l., 1999). In addition, we have examined the effect of
ecretion on total production of -toxoid. Finally, we
ave tested whether the rpsF promoter of B. subtilis
an advantageously be used for -toxoid production in
ther Gram-positive heterologous hosts, such as Lac-
ococcus lactis and Streptococcus pneumoniae.
. Materials and methods
.1. Bacterial strains, medium and growth
onditions
Table 1 lists the bacterial strains and plasmids
sed in this study. B. subtilis strains were grown
t 37 ◦C under vigorous agitation in TY (1% tryp-
one, 0.5% yeast extract, 1.0% NaCl) or minimal
edium (Spizizen, 1958). L. lactis strains were grown
t 30 ◦C in M17 broth with 0.5% glucose (GM17)
Terzaghi and Sandine, 1975).S. pneumoniawas grown
t 37 ◦C in GM17 broth. For the selection of trans-
ormants, appropriate antibiotics were added to the
rowth media at the following concentrations: for
. subtilis erythromycin 2g ml−1, chloramphenicol
g ml−1, spectinomycin 100g ml−1, hygromycin
25g ml−1; for L. lactis chloramphenicol 5g ml−1
nd erythromycin 5g ml−1; for S. pneumoniae ery-
hromycin 0.25g ml−1. A 1% starch was added to
olid media to visualise amylase activity when appro-
riate.
.2. Strain constructions and transformation
The cloning and transformation procedures were
erformed according to established techniques (Bron
nd Venema, 1972; Sambrook et al., 1989) and sup-
lier’s manuals. Restriction enzymes, DNA poly-
erases, deoxynucleotides, T4 DNA ligase, plasmid
solation kits and PCR-product purification kits were
btained from Roche Diagnostics (Mannheim, Ger-
any), and used as specified by the supplier. For all
CR-reactions PWO polymerase was used unless spec-
fied differently. Nucleotide sequences of primers used
or PCR are listed in Table 2.
The rpsF and yukE promoter fragments were ampli-
ed by PCR from B. subtilis 168 chromosomal DNA
sing primers rpsF-3 and rpsF-5, and pyukE4-fw and
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Table 1
Strains and plasmids used in this study
Strains Genotype Reference
B. subtilis 168 trpC2 Anagnostopoulos and Spizizen (1961)
B. subtilis WB700 nprE aprE epr bpr mpr::ble nprB::bsr vpr Wu et al. (2002)
B. subtilis WB800 nprE aprE epr bpr mpr::ble nprB::bsr vpr wprA::hyg Wu et al. (2002)
B. subtilis DN2 168 amyE::PhtrA-bgaB Noone et al. (2000)
L. lactis MG1363 Plasmid-free strain Gasson (1983)
L. lactis NZ9000 pepN::NisRK Kuipers et al. (1998)
S. pneumonia D39 Serotype 2, virulent strain, NCTC 7466 Avery et al. (1944)
Plasmids Characteristics and description Reference
pTRKH2 EryR, high copy, theta replicating O’Sullivan and Klaenhammer (1993)
pDH32M CmR, AmyE-integration vector Kraus et al. (1994)
pRBT pTRKH2::PrpsF- toxoid-gntT This study
pRST pTRKH2::PrpsF- toxoid without SS-gntT This study
pRAT pTRKH2::PrpsF-amyQ-gntT This study
pRN1 pTRKH2:-NdeI–NdeI This study
pYBT pTRKH2::PyukE- toxoid-gntT This study
pYST pTRKH2::PyukE- toxoid without SS-gntT This study
pYAssBT pTRKH2::PyukE-amyQ signal sequence-mature  toxoid-gntT This study
pIV60 pDH32M::PrpsF- toxoid-gntT This study
pNZ8048 reflective vector containing nisin inducible promoter Pnis de Ruyter et al. (1996)








































mKTH10 Replicative plasmid containing AmyQ
Btox1 his6-toxoid-his6
yukE4-rv, respectively. B. subtilis yukE is a gene of
nknown function that probably has not correctly been
nnotated in the B. subtilis R16.1 annotation as avail-
ble on SubtiList (Moszer et al., 1995), since the most
ikely promoter and ribosome binding site sequences
verlap with the annotated open reading frame. Fur-
hermore, in all annotated homologs found, the anno-
ated first 8 amino acids are absent. We therefore
ssumed that not the first ATG codon but the sec-
nd ATG codon, starting at basepair 25, is the actual
tart codon, and we have cloned the promoter accord-
ngly.
The -toxoid gene was amplified by PCR using
rimers Btox-RN1-fw and 2Btoxoid2 and pBtox1 plas-
id as a template. The -toxoid gene without signal
equence (β-toxoid-SS) was amplified from the same
emplate using primers Btoxoid-ss+ATG and 2Btox-
id2. amyQ was amplified using primers AmyQ2-fw
nd AmyQ-rv and pTKH10 plasmid as a template. The
nt-terminator structure was amplified using Exten-
or polymerase (ABgene, Epson, United Kingdom), B.





BDarmon et al. (2002)
Intervet Int., Boxmeer, NL
After amplification, the promoter fragments were
igested by NdeI. The β-toxoid, β-toxoid-SS, and
myQ PCR fragments were digested by NdeI and
amHI. The gnt-terminator (gntT) was digested
amHI. All digested fragments were purified using
he High pure PCR-purification kit, and ligated in a
hree point ligation using T4 DNA ligase. The com-
lete expression cassettes were subsequently amplified
y PCR directly from the ligation mixture. When this
CR did not yield a single fragment, the fragment of
he right size was isolation from gel using a High Pure
CR Product Purification Kit.
Purified expression cassettes were digested with
stI and HpaI, and ligated into a SmaI/PstI digested
TRKH2 high copy vector.
The single copy integration plasmid pIV60 was
onstructed by ligation of the PrpsF-β-toxoid-gntT
assette in pDH32m. To construct a fusion of the
ature -toxoid gene to the AmyQ signal sequence,he AmyQ signal sequence was amplified using primers
myQfw-2 and AmyQ ss-rv. The DNA fragment
ncoding mature -toxoid was amplified using primers
tox-mature-fw and 2Btoxoid-2. Both fragments were
364 R. Nijland et al. / Journal of Biotechnology 127 (2007) 361–372
Table 2
Primers used in this study
Primer name Description Sequence (5′–3′)a
rpsF-3 Forward primer to amplify the rpsF
promoter region
GGAATTCCTGCAGGTGACTTTGAGCGGGGCTTC
rpsF-5 Reverse primer to amplify the rpsF)
promoter region with RBS and ATG
CGTACTTTCTCATATGTTTGCACC
Gnt-term-3 Forward primer for gnt-terminator GCGGATCCTACGTAAACTAATTAACCTGTATTAAAAACACG
Gnt-term-2 Reverse primer for gnt-terminator GCTCTAGAGTTAACCTTCTGTTGTTTGGGATAG
Btoxoid-RN1-fw Forward primer for -toxoid GCGTCTAGACATATGAAGAAAAAATTTATTTCATTAGTTATAG
Btoxoid-ss+ATG Forward primer for -toxoid without
signal sequence
GCTCTAGACACATATGAATGATATAGGTAAAACTACTACTATAA
2B-toxoid2 Reverse primer for -toxoid CGCGGATCCTTAAATAGCTGTTACTTTGTGAG
Btoxoid-RN2-fw Forward primer for -toxoid cloning in
pNZ8048
CGTTGCCATGGAGAAAAAATTTATTTCATTAGTTATAG
Btoxoid-RN2-rv Reverse primer for -toxoid cloning in
pNZ8048
CGCTCTAGATTAAATAGCTGTTACTTTGTGAG
Btox-mature-fw Forward primer for mature -toxoid,
enabling fusion to signal sequences
CGGTCTCAAATGATATAGGTAAAACTACTACTATAA
pyukE4-fw Forward primer for yukE promoter
region
GCAACTGCAGCGGAGGCAAGACTAATTAAG
pyukE4-rv Reverse primer for yukE promoter region
with RBS and ATG
TAATCCTGCCATATGCCTCATTACCT
amyQfw-2 Forward primer to amplify amyQ CAATACGCATATGATTCAAAAACGAAAGC
AmyQrv Reverse primer to amplify amyQ GCGGATCCTCAGCTTGGAGGTGTTT
AmyQ ss-rv Reverse primer for AmyQ-signal




































2NlacZ-fw Universal primer on puc18 derived MCS
NlacZ-rv Universal primer on puc18 derived MCS
a Underlined nucleotides indicate introduced hexameric restriction
igested with Eco31I and ligated, resulting in a gene
ncoding an exact fusion of the AmyQ signal sequence
o the mature -toxoid at the signal peptidase cleavage
ite. The fused DNA was amplified by PCR from the
igation mixture and digested by NdeI and BamHI, and
igated in the likewise digested pYBT plasmid, result-
ng in pYAssBT.
pNZbtox was constructed by ligation of a NcoI
nd PstI digested -toxoid PCR product, resulting
rom a PCR on pBtox-1 using primers Btox-RN2-fw
nd Btox-RN2-rv, into the likewise digested vector
NZ8048. An overview of all constructed plasmids is
iven in Table 1.
All ligation mixtures were transferred to electro-
ompetent L. lactis MG1363 or L. lactis NZ9000 using
Gene pulser (Biorad laboratories, Hercules, Califor-
ia), as described earlier (Leenhouts et al., 1989).
Colonies were selected on solid media for the
ppropriate antibiotic resistance and were subsequently




ids were isolated, which were inspected by EcoRI-
igestion and DNA-sequencing.
B. subtilis 168, WB700 or WB800 were trans-
ormed with the constructed replicative plasmids iso-
ated from L. lactis, and selected on solid medium for
rythromycin resistance. B. subtilis strain BIV60 was
btained by a double crossover of plasmid pIV60 into
he chromosomal amyE gene of B. subtilis WB700. S.
neumonia D39 was transformed by growing the strain
t 37 ◦C in GM17 to an OD600 of 0.1; competence-
timulating protein CSP-1 (Pozzi et al., 1996) was used
t 100 ng ml−1 for inducing competence. Transformed
ells were selected on solid medium for erythromycin
esistance.
.3. Protein isolation, gel electrophoresis and
estern blotting
Strains were grown as described and growth was







































































which was performed as follows. Monoclonal antibody
against native -toxin F126 was coated in 96 wells
plate overnight. The plate was blocked for 2 h with 1%
PBS-T-BSA. In a separate plate the mice sera were
Table 3
Preparation of the vaccine
Vaccine Approximately -toxoid
concentration (g/ml)
Mean titer ± S.D.
1 10.8 32 ± 15R. Nijland et al. / Journal of
rom an OD600 of 0.7 onwards, every hour, 2.0 ml
amples were taken from the cultures. The cells were
mmediately separated from the supernatant by cen-
rifugation for 1 min at 14,000 rpm, and cells and super-
atant were separately frozen in liquid nitrogen. When
he sample collection was finished all samples were
hawed on ice. Cell fractions of B. subtilis and S. pneu-
onia were prepared for SDS-PAGE as described pre-
iously (Veening et al., 2004). ForL. lactis this protocol
as adjusted and the cells were protoplasted at 50 ◦C
nstead of the described 37 ◦C. Supernatant fractions
ere concentrated 10 times upon trichloroacetic acid
TCA) precipitation, and samples for SDS-PAGE were
repared as described previously (Laemmli, 1970).
roteins were separated by SDS-PAGE, and either
tained with Coomassie Brilliant Blue directly, or trans-
erred to a polyvinylidene-difluoride (PVDF) mem-
rane (Molecular Probes Inc., Eugene, Oregon). -
oxoid protein was visualised using a monoclonal anti-
-toxoid antibody (Intervet Int., Boxmeer, NL), and
secondary horse radish peroxidase-conjugated goat
nti-mouse antibody (Amersham Biosciences, Buck-
nghamshire, UK). -Toxoid concentrations were esti-
ated using dilution series loaded on a Coomassie
rilliant blue stained polyacrylamide gel with a Bovine
erine Albumin standard as reference.
.4. β-Galactosidase activity assay
To assay -galactosidase activities, overnight cul-
ures were diluted in fresh medium, and samples were
aken at hourly intervals for optical density readings at
00 nm (OD600) and -galactosidase activity determi-
ations. The -galactosidase assay, and the calculation
f-galactosidase units (Miller units), were performed
s described (Miller, 1982), with the adaptations for the
eat resistant bgaB variant as described by Darmon et
l. (2002).
.5. Addition of β-toxoid to growing cultures of B.
ubtilis
B. subtilis 168 was grown as described with a start-
ng OD of 0.01. OD was measured every hour,600 600
nd after 2 h of growth -toxoid was added at final
oncentrations of 2.0 and 5.0g ml−1. Growth was fol-
owed by OD600 measurements until cells were 4 h into
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. lactis culture harbouring the pRBT plasmid. Whole
upernatant of this L. lactis culture was concentrated
sing TCA precipitation. As a control, concentrated
upernatant of a L. lactis strain containing an empty
ector was used.
.6. Automated growth assays and nisin-induction
f β-toxoid production in L. lactis NZ9000
For automated growth assays a Genious microplate
eader (Tecan Instruments, Maennedorf, Switzerland)
as used, using 96 well flat bottom microplates con-
aining 200l of GM17 medium with antibiotics, inoc-
lated with O/N grown L. lactis strains diluted to an
D595 of 0.1. The strains were grown at 30 ◦C and the
D was measured every 20 min after orbital shaking
or 15 s to prevent sedimentation. After 2 h of growth,
isin from a culture supernatant of strain NZ9700 (de
uyter et al., 1996) was added to half of the samples at a
:1000 dilution, and growth was monitored for another
0 h while measuring optical density. From a separate
icroplate, the cultures from five wells were pooled 2 h
fter nisin-induction. These samples were separated in
ell and supernatant fraction, and analyzed for-toxoid
roduction and secretion.
.7. Biological activity of L. lactis produced
-toxoid
Female mice weighing 18–22 g were immunized IP
n day 0 and day 14 with 250l antigen in Diluvac
orte as outlined in Table 3. The mice were bled on
ay 28.
The obtained sera were used in a competitive ELISA5.4 14 ± 19
2.7 11 ± 13
1.3 15 ± 14
0.7 <4











































Fig. 1. -Toxoid production in B. subtilis. (A) Coomassie brilliant
blue stained SDS-poly acrylamide gel of whole cell extracts from
B. subtilis 168 containing the pRST high copy vector or an empty
vector control. Lane 1: 168 harbouring pTRKH2 (empty vector).
Lane 2: 168 harbouring the pRST plasmid Lane 3 shows the pro-
tein marker (Dual stain, Biorad). The arrow indicates the -toxoid
protein. The abundant protein band at 25 kDa is likely to resemble
the Erm protein conferring erythromycin resistance present on the
pTRKH2 vector. The concentration of-toxoid in lane 2 is 25% of the
total extracellular protein. (B) Western blot of supernatant fractions
of B. subtilis BIV60 culture containing a single copy integration of
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itrated three-fold, native -toxin was added as a fix
oncentration to all wells. The antibodies were allowed
o react with the -toxin for 30 min at 37 ◦C and then
ransferred to the Mab coated plate. The plates were
ncubated at room temperature for 1 h. Horse radish
eroxidase conjugate rabbit polyclonal antibodies were
dded and incubated for 1 h. After washing the plates
ere colorimetrically developed with OPD. Titers were
alculated as half of the maximum OD490 of the nega-
ive control relative to the internal serum control, which
as defined as titer 50 i.u. ml−1.
. Results
.1. β-Toxoid production in B. subtilis
Previously, we have investigated the expression pat-
ern of the strong ribosomal promoter rpsF inB. subtilis
Lindner et al., 2004). To test suitability and efficacy
f this promoter for heterologous expression of -
oxoid, we constructed the high copy theta replicating
xpression plasmid pRST, containing the B. subtilis
psF-promoter and C. perfringens -toxoid gene with-
ut its endogenous signal sequence. This construct was
ntroduced in B. subtilis 168 and resulted in high intra-
ellular -toxoid expression, up to 200g ml−1 cul-
ure, corresponding to 25% of total intracellular protein
Fig. 1A).
To test a secretion construct of -toxoid, a plasmid
as constructed containing the B. subtilis rpsF pro-
oter and the-toxoid gene with its original clostridial
ignal sequence (pRBT). Unfortunately, this plasmid
ould not be stably maintained in B. subtilis. Several
ttempts to construct this clone failed or resulted in
trains that grew poorly and lost the plasmid after
vernight growth. A single copy integration into the
ctopic amyE locus did yield a stable strain. However,
ardly any -toxoid could be detected in the medium
data not shown). To test whether this could be due to
he expression vector used, we tested the production
nd secretion of AmyQ, the alpha-amylase of B.
myloliquefaciens, which is widely used for testing
ecretion efficiencies in B. subtilis (Vitikainen et al.,
001; Hyyrylainen et al., 2001; Westers et al., 2004).
he introduction of the vector with the rpsFpromoter in
ront of amyQ (pRAT) resulted in high-level secretion




ooaded were corrected for OD. Numbers indicate time during growth
n hours, where T0 is the transition from logarithmic growth to sta-
ionary growth. (+) Positive control (C. perfringens -toxin).
ystem itself is capable of yielding high secretory
evels.
To further investigate the bottlenecks in -toxoid
ecretion we investigated the possibility that accumu-
ation of secreted -toxoid in the medium is toxic to
. subtilis. We therefore tested growth of B. subtilis
n medium with externally added -toxoid. No effect
n growth was observed even when extracellular con-
entrations were five times higher than the maximal
oncentration observed in a -toxoid producing strain;
hus, low production is not a consequence of external
oxicity (data not shown).
B. subtilis is well known for its capability of pro-
ucing degradative enzymes, especially during sta-
ionary growth. It is therefore possible that -toxoid
s degraded when in it is secreted into the medium.
o test this, the expression cassette was integrated
n the amyE locus of a B. subtilis strain WB700 in
hich seven of the major extracellular proteases are
eleted (Wu et al., 2002). In this strain, secreted -
oxoid was detected in the medium at concentrations
f 0.1–0.5g ml−1 culture. Expression was highest
R. Nijland et al. / Journal of Biotech
Fig. 2. -Toxoid secretion in protease deficient B. subtilis mutants
from the pYBT plasmid. Western blot showing cell and supernatant
fractions of -toxoid produced by two protease deficient B. sub-
tilis strains, WB700 and WB800. Numbers indicate the time during
growth in hours, where T0 is transition from logarithmic growth to
stationary growth. Upper panels show intracellular accumulated and
secreted -toxoid in WB700, lower panels show intracellular accu-
mulated and secreted -toxoid in WB800. Amounts loaded were





































































rion per cell. Supernatant fraction contain 4× more culture volume
ompared to the cell pellets. : -Toxoid; p-: pre--toxoid.
uring logarithmic growth and still present in station-
ry growth (Fig. 1B).
Unfortunately, the use of a single copy integra-
ion of the expression cassette in the amyE locus
esults in the production of only low levels of -
oxoid. By using a different strong promoter it might
e possible to obtain a stable multicopy construct car-
ying the -toxoid gene. The B. subtilis yukE pro-
oter is strong, however its expression timing differs
rom that of the rpsF promoter. YukE expression is
ighest during the transition from logarithmic to sta-
ionary growth phase when the cells are grown in
ich medium (MICADO, http://locus.jouy.inra.fr/cgi-
in/genmic/madbase home.pl, Biaudet et al., 1997).
ndeed, it proved to be possible to introduce the PyukE
ontaining vector into B. subtilis 168 and WB700 with-
ut severe effects on cell growth. As shown in Fig. 2,
n B. subtilis WB700 the expression of -toxoid started
t the end of logarithmic growth and showed highest
ecretion around transition point. WB800 is the same as
. subtilis strain as WB700 except that the major cell-
all proteases wprA is deleted as well. Introduction
f plasmid pYBT in this strain resulted in consider-
bly more -toxoid in the medium (0.5–1.0g ml−1),
howing the involvement of WprA in secreted-toxoid
reakdown. Notably, during all time points measured
bout twice as much -toxoid was present intracellu-
arly compared to the secreted fractions, indicating that
ecretion is a bottleneck in the production of -toxoid
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equence since swapping with amyQ gave no improve-
ent. To test whether the signal peptide of -toxoid
rotein is the bottleneck we swapped it with the signal
eptide of AmyQ, which can be secreted in B. subtilis
o high amounts (Vitikainen et al., 2001). However, this
id not yield more secreted-toxoid, indicating that the
ignal peptide itself is not the limiting factor (data not
hown).
.2. β-Toxoid secretion causes secretion stress in
. subtilis
To investigate whether the inefficient -toxoid
ecretion may lead to a stress response in B. subtilis,
e made use of strain DN2 (Noone et al., 2000) con-
aining the promoter of htrA fused to a thermostable
-galactosidase gene integrated in the amyE locus
amyE::PhtrA-bgaB). The B. subtilis HtrA protease
s involved in the folding of secreted proteins and
he degradation of malfolded proteins after secretion
Pallen and Wren, 1997). Its expression is upregulated
n response to overexpression of secreted proteins, the
o called secretion stress response. This response is
ctivated by the two component sensor system CssRS
Darmon et al., 2002). As shown in Fig. 3, the produc-
ion of -toxoid results in a strong induction of htrA
xpression. This effect is not observed when cssS is
eleted or when -toxoid was expressed without sig-
al sequence (data not shown). Together these data
learly indicate that -toxoid secretion results in secre-
ion stress in B. subtilis.
.3. The rpsF expression system in other
ram-positive bacteria
The rpsF-ssb-rpsR operon is conserved among
any Gram-positive bacteria. An alignment of the
pstream regions of the rpsF-ssb-rpsR operons of
. subtilis, L. lactis and S. pneumoniae was made
sing Genedoc (http://www.psc.edu/biomed/genedoc).
s shown in Fig. 4, the promoter regions are highly
imilar. The pRBT plasmid (PrpsF-β-toxoid) was intro-
uced inL. lactisMG1363 and S. pneumoniaeD39, and
esulted in 5–10g ml−1 of secreted -toxoid (Fig. 5).
n L. lactis -toxoid up to 30% of the total secreted
roteins in the medium consisted of-toxoid. This con-
iderable production shows that the rpsF promoter ofB.
ubtilis is active in L. lactis and S. pneumonia, and that
368 R. Nijland et al. / Journal of Biotechnology 127 (2007) 361–372



































ropen symbols) of PhtrA-bgaB reporter strain containing either no pla
DN2 + pYBT).
he -toxoid signal sequence functions as an efficient
xport signal in both organisms.
To study the strength of the rpsF expression system
n L. lactis, we compared it to results obtained with the
isin inducible expression system (NICE). The NICE
ystem is generally regarded as one of the best produc-
ion systems in L. lactis where the maximally produced
mount of protein is limited only by the organisms pro-
uction bottlenecks for the specific protein (de Ruyter
t al., 1996). As shown in Fig. 5, the rpsF expression
ystem yields similar levels of secreted -toxoid as
nduction with the nisin inducible promoter, demon-
trating the rpsF expression system provides a very
fficient broad host range production platform.
.4. Immunity and biological activity of β-toxoidTo determine biological activity and immunogenic
roperties the -toxoid was not purified. Instead total





ig. 4. Alignment of the rpsF promoter sequences. Alignment of B. subti
egions. The start codon of rpsF (start), −35 and −10 promoter sequences,N2), empty vector (DN2 + pRN1), or -toxoid expression construct
clear cost-advantage over purification, and has no
dverse effects on the animals health (Norton et al.,
994). Material produced in L. lactis MG1363 was
ested for both biological activity and immunogenic
roperties. Toxicity of the -toxoid was tested in
ice. The -toxoid, specifically constructed to have
reduced toxicity, is indeed non-toxic at levels at
hich the wild-type toxin is lethal. When 2.5g/mouse
average weight 20 g) was administered 5/5 mouse sur-
ived. The -toxoid was toxic when administered at
0g/mouse (0/2 survived). These results show a tox-
city reduction of three orders of magnitude compared
o the WT -toxin, which has a LD50 of 0.4g/kg in
ouse (i.v.) (Gill, 1982).
To test immunogenic properties of -toxoid vac-
ines were prepared as described in the materials and
ethods section with -toxoid concentrations as out-
ined in Table 3. The mice were immunized according
o a standard protocol and 14 days after second immu-
ization, the animals were bled. Anti-toxin antibodies
lis 168, L. lactis MG1363 and S. pneumoniae D39 rpsF promoter
and RBS are indicated.
R. Nijland et al. / Journal of Biotech
Fig. 5. -Toxoid expression in L. lactis and S. pneumoniae. Upper
panels: -toxoid expression in L. lactis. (A) CBB stained PAA gel
of culture supernatant of strain containing nisin inducible -toxoid
production plasmid, 2 h after addition of nisin (+) or buffer (−). (B)
CBB stained PAA gel of culture supernatant of MG1363 containing
the pRBT plasmid. -Toxoid is indicated by the arrows. (C) Western
blot of culture supernatant of strain containing nisin inducible -
toxoid, 2 h after addition of nisin (+) or buffer (−). (D) Western blot
of culture supernatant of MG1363 containing the pRBT plasmid. -
Toxoid visualized using monoclonal anti--toxoid antibody. Lower
panels: -toxoid expression in S. pneumoniae. (E) CBB stained PAA
gel of culture supernatant and cell fractions, and (F) Western blot of



















































nal sequence is a consensus Sec-type signal sequence,clonal anti--toxoid antibody. -Toxoid is indicated by the arrows.
−) Strain containing an empty vector control. (+) Strain containing
he pRBT expression plasmid.
ere determined as titers relative to WHO International
tandard in a competitive ELISA which shows results
omparable to European Pharmacopoeia (Ph.Eur.) (or
CFR test). Both Ph.Eur. and 9 CFR require that a
accine induces 10 neutralizing international units in
verage in 10 rabbits, tested as neutralization in mice.
ll vaccine induced titers in mice with the exception
f the vaccine preparation with lowest concentration of
he antigen (Table 3).
a
s
snology 127 (2007) 361–372 369
. Discussion and conclusion
To obtain high yields of any heterologous protein,
he use of a strong promoter is a prerequisite. In this
esearch we show that the promoter of the B. subtilis
ibosomal rpsFgene is a strong promoter that is capable
f high expression of C. perfringens -toxoid intracel-
ularly. However, high production of -toxoid in the
rowth medium turned out to be impossible. In fact,
he presence of the complete -toxoid gene (including
ecretion signals) under expression of the rpsF pro-
oter on a high copy vector was lethal. Our evidence
uggests that high expression of-toxoid leads to a con-
iderable stress, which, when pushed to the limits by a
trong promoter as rpsF, is apparently toxic to the cells.
hese results also imply that the rpsF expression sys-
em does not autoregulate itself as we have postulated
n Section 1. We anticipated to find that a cell growth
ependent promoter would slow down the transcription
f the protein cloned behind it when the produced pro-
ein causes stress that slows down the growth, resulting
n an equilibrium with optimal growth rate and protein
roduction. However, the stress on cell growth did not
esult in a sufficient decrease in -toxoid expression to
revent plasmid instability and cell death.
B. subtilis is able to secrete several proteins up to
0 g l−1 (Schallmey et al., 2004), however it is know
hat secretion of heterologous proteins in B. subtilis
s usually lower (Li et al., 2004). A frequently encoun-
ered problem with expression and secretion of heterol-
gous proteins in B. subtilis is the rapid degradation
f the secreted protein by extracellular proteases (Wu
t al., 2002). It has also been reported that -toxoid
s sensitive to protease activity (Hunter et al., 1993).
herefore, it was not surprising to find that employ-
ng extracellular protease deficient B. subtilis strains
ncreased the amounts of -toxoid in the medium con-
iderably.
.1. Secretion signals
It was previously shown, that adapting the signal
equence can improve protein secretion (Schallmey
t al., 2004). The C. perfringens -toxoid native sig-nd in theory compatible with the B. subtilis secretion
ystem (Tjalsma et al., 2000). Swapping the -toxoid
















































































N70 R. Nijland et al. / Journal of
ecreted Bacillus protein (AmyQ) did not increase its
resence in the growth medium. Apparently, the -
oxoid signal sequence itself is not responsible for the
oor secretion. These findings are in agreement with
revious studies on the production of wildtype-toxin,
hich has different properties than the -toxoid, but
ontains the same signal sequence (Steinthorsdottir et
l., 1998, 2000). Most likely the poor secretion and/or
ow extracellular stability is caused by characteristics
f the mature -toxoid protein, for instance by prema-
ure folding in the absence of suitable chaperones or
apid degradation due to slow folding kinetics directly
fter secretion at the cell membrane cell-wall interface.
he expression of the gene encoding the B. subtilis
trA protease is upregulated in response to overexpres-
ion of -toxoid which is indicative for secretion stress
Fig. 3). Induction of HtrA is related to problems that
ccur in late stages of protein secretion (Leloup et al.,
997), presumably as a consequence of slow folding at
he membrane-cell-wall interface (Braun et al., 1999).
he response of the cells to secretion stress appears to
e not sufficient to increase -toxoid secretion, as the
ccumulation of non-secreted -toxoid intracellularly
ndicates.
.2. Broad host range expression system
pTRKH2 is a stably replicating vector in a broad
ange of Gram-positive micro-organisms (O’Sullivan
nd Klaenhammer, 1993), making it a suitable broad
ost range vector. In addition, the rpsF promoter is well
onserved in all Gram-positive organisms. Together,
hese genetic elements form a potential versatile pro-
ein expression system, which we have illustrated here
y the heterologous production of -toxoid in both L.
actis and S. pneumoniae. The expression yield of -
oxoid in L. lactis using the rpsF promoter was as high
s the yield using the NICE expression system, showing
hat also in L. lactis the rpsF promoter on a high copy
ector results in maximum obtainable expression lev-
ls of secreted protein in these organisms. As apparent
rom the results obtained, the secretion of -toxoid in
. subtilis encounters bottlenecks that are less severe
n L. lactis or S. pneumoniae. A likely bottleneck is
egradation of the protein by a B. subtilis specific pro-
eases that are absent in the other organisms. We are
urrently investigating the exact nature of this and other
ottlenecks. With this study we have shown that an
R
Anology 127 (2007) 361–372
pportunistic broad host range strategy can be advan-
ageous to achieve optimal protein secretion yields,
here it cannot,apriori, be predicted which host would
e most suitable.
.3. Applicability
As shown by the immunity and biological activ-
ty experiments the produced -toxoid has substantial
educed toxicity and still induces high titers in vac-
ination experiments. These results indicate that the
-toxoid is a very suitable vaccine component against
. perfringens type B and C.
-Toxoid in L. lactis was produced in culture flasks
sing standard medium. Induction of expression using
he NICE system yielded sufficient amounts of -
oxoid for in small scale experiments. Until recently
xperience with large-scale application and fermenta-
ion of the NICE system was very limited. However,
ecent publications showed that the NICE system is
ell suited to produce target protein at industrial scale.
areful optimization of key parameters, like pH con-
rol, medium, and spore elements, leads to a significant
ncrease in target protein yields (Mierau et al., 2005a,b),
ndication that also of -toxoid commercially interest-
ng yield are within reach.
cknowledgements
We would like to thank Piet Nuijten and Ruud Segers
or supplying the pBtox1 plasmid and the anti--toxin
onoclonal antibody and for helpful discussions. Paul
ermeij (Intervet International B.V.) is acknowledged
or the outstanding performance of the vaccination
xperiments. Jetta Bijlsma is acknowledged for assis-
ance with the S. pneumoniae work. We thank Vincent
alk and Renze Borger for general technical assistance.
e thank Wiep Klaas Smits and Jan-Willem Veening
or critically reading of the article. This work was sup-
orted by Intervet International B.V. (Boxmeer, The
etherlands).eferences
nagnostopoulos, C., Spizizen, J., 1961. Requirements for transfor-

































SR. Nijland et al. / Journal of
very, O.T., MacLeod, C.M., McCarty, M., 1944. Studies on the
chemical nature of the substance inducing transformation of
pneumococcal types. Inductions of transformation by a desoxyri-
bonucleic acid fraction isolated from pneumococcus type III. J.
Exp. Med. 79, 137–158.
iaudet, V., Samson, F., Bessieres, P., 1997. Micado—a network-
oriented database for microbial genomes. Comput. Appl. Biosci.
13, 431–438.
raun, P., Gerritse, G., van Dijl, J.M., Quax, W.J., 1999. Improv-
ing protein secretion by engineering components of the bacterial
translocation machinery. Curr. Opin. Biotechnol. 10, 376–381.
ron, S., Venema, G., 1972. Ultraviolet inactivation and excision-
repair in Bacillus-subtilis. 1. Construction and characterization
of A transformable eightfold auxotrophic strain and 2 ultraviolet-
sensitive derivatives. Mutat. Res. 15, 1–8.
armon, E., Noone, D., Masson, A., Bron, S., Kuipers, O.P., Devine,
K.M., Dijl, J.M.V., 2002. A Novel class of heat and secretion
stress-responsive genes is controlled by the autoregulated CssRS
two-component system of Bacillus subtilis. J. Bacteriol. 184,
5661–5671.
e Ruyter, P.G., Kuipers, O.P., de Vos, W.M., 1996. Controlled gene
expression systems for Lactococcus lactis with the food-grade
inducer nisin. Appl. Environ. Microbiol. 62, 3662–3667.
asson, M.J., 1983. Plasmid complements of Streptococcus lactis
NCDO 712 and other lactic streptococci after protoplast-induced
curing. J. Bacteriol. 154, 1–9.
ill, D.M., 1982. Bacterial toxins: a table of lethal amounts. Micro-
biol. Rev. 46, 86–94.
arwood, C.R., 1992. Bacillus subtilis and its relatives: molecu-
lar biological and industrial workhorses. Trends Biotechnol. 10,
247–256.
unter, S.E., Brown, J.E., Oyston, P.C., Sakurai, J., Titball, R.W.,
1993. Molecular genetic analysis of beta-toxin of Clostrid-
ium perfringens reveals sequence homology with alpha-toxin,
gamma-toxin, and leukocidin of Staphylococcus aureus. Infect.
Immun. 61, 3958–3965.
yyrylainen, H.L., Bolhuis, A., Darmon, E., Muukkonen, L., Koski,
P., Vitikainen, M., Sarvas, M., Pragai, Z., Bron, S., van Dijl, J.M.,
Kontinen, V.P., 2001. A novel two-component regulatory system
inBacillus subtilis for the survival of severe secretion stress. Mol.
Microbiol. 41, 1159–1172.
raus, A., Hueck, C., Gartner, D., Hillen, W., 1994. Catabolite
repression of the Bacillus subtilis xyl operon involves a cis ele-
ment functional in the context of an unrelated sequence, and
glucose exerts additional xylR-dependent repression. J. Bacte-
riol. 176, 1738–1745.
uipers, O.P., de Ruyter, P.G., Kleerebezem, M., de Vos, W.M., 1998.
Quorum sensing-controlled gene expression in lactic acid bacte-
ria. J. Biotech. 64, 15–21.
aemmli, U.K., 1970. Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature 227, 680–685.
eenhouts, K.J., Kok, J., Venema, G., 1989. Campbell-like inte-
gration of heterologous plasmid DNA into the chromosome of
Lactococcus lactis subsp. lactis. Appl. Environ. Microbiol. 55,
394–400.
eloup, L., Haddaoui, E.A., Chambert, R., Petit-Glatron, M.F., 1997.
Characterization of the rate-limiting step of the secretion ofBacil-
Snology 127 (2007) 361–372 371
lus subtilis alpha-amylase overproduced during the exponential
phase of growth. Microbiology 143, 3295–3303.
i, W., Zhou, X., Lu, P., 2004. Bottlenecks in the expression and
secretion of heterologous proteins in Bacillus subtilis. Res.
Microbiol. 155, 605–610.
indner, C., Nijland, R., van, H.M., Bron, S., Hamoen, L.W., Kuipers,
O.P., 2004. Differential expression of two paralogous genes of
Bacillus subtilis encoding single-stranded DNA binding protein.
J. Bacteriol. 186, 1097–1105.
iller, J.H., 1982. Experiments in Molecular Genetics. Cold Spring
Harbor Laboratory Press, Cold Spring Harbor, NY.
ierau, I., Leij, P., van, S.I., Blommestein, B, Floris, E, Mond, J,
Smid, E.J., 2005a. Industrial-scale production and purification
of a heterologous protein in Lactococcus lactis using the nisin-
controlled gene expression system NICE: the case of lysostaphin.
Microb. Cell Fact. 4, 15.
ierau, I., Olieman, K., Mond, J., Smid, E.J., 2005b. Optimization of
the Lactococcus lactis nisin-controlled gene expression system
NICE for industrial applications. Microb. Cell Fact. 4, 16.
oszer, I., Glaser, P., Danchin, A., 1995. SubtiList: a relational
database for the Bacillus subtilis genome. Microbiology 141 (Pt.
2), 261–268.
oone, D., Howell, A., Devine, K.M., 2000. Expression of ykdA,
encoding a Bacillus subtilis homologue of HtrA, is heat
shock inducible and negatively autoregulated. J. Bacteriol. 182,
1592–1599.
orton, P.M., Brown, H.W.G., Le Page, R.W.F., 1994. The immune
response to Lactococcus lactis: implications for its use as a vac-
cine delivery vehicle. FEMS Microbiol. Lett. 120–123, 249–
256.
’Sullivan, D.J., Klaenhammer, T.R., 1993. High- and low-copy-
number Lactococcus shuttle cloning vectors with features for
clone screening. Gene 137, 227–231.
allen, M.J., Wren, B.W., 1997. The HtrA family of serine proteases.
Mol. Microbiol. 26, 209–221.
ozzi, G., Masala, L., Iannelli, F., Manganelli, R., Havarstein, L.S.,
Piccoli, L., Simon, D., Morrison, D.A., 1996. Competence for
genetic transformation in encapsulated strains of Streptococcus
pneumoniae: two allelic variants of the peptide pheromone. J.
Bacteriol. 178, 6087–6090.
ambrook, J., Fritsch, E.F., Maniatis, T., 1989. Molecular Cloning:
A Laboratory Manual. Cold Spring Harbour Laboratory, Cold
Spring Harbour, NY.
challmey, M., Singh, A., Ward, O.P., 2004. Developments in the use
of Bacillus species for industrial production. Can. J. Microbiol.
50, 1–17.
egers, R.P.A.M., Waterfield, N.R., Frandsen, P.L., Wells, J.M.
Clostridium perfringens vaccine [EP0892054]. 1999. EUR. Ref
Type: Patent.
onger, J.G., 1996. Clostridial enteric diseases of domestic animals.
Clin. Microbiol. Rev. 9, 216–234.
pizizen, J., 1958. Transformation of biochemically deficient strains
of Bacillus subtilis by deoxyribonucleate. Proc. Natl. Acad. Sci.
U. S. A 44, 1072–1078.
pringer, S., Selbitz, H.J., 1999. The control of necrotic enteritis in
sucking piglets by means of a Clostridium perfringens toxoid










Wong, S.L., 2002. Functional production and characterization72 R. Nijland et al. / Journal of
teinthorsdottir, V., Fridriksdottir, V., Gunnarsson, E., Andresson,
O.S., 1998. Site-directed mutagenesis ofClostridiumperfringens
beta-toxin: expression of wild-type and mutant toxins in Bacillus
subtilis. FEMS Microbiol. Lett. 158, 17–23.
teinthorsdottir, V., Halldorsson, H., Andresson, O.S., 2000.
Clostridium perfringens beta-toxin forms multimeric transmem-
brane pores in human endothelial cells. Microb. Pathog. 28,
45–50.
erzaghi, B.E., Sandine, W.E., 1975. Improved medium for lac-
tic streptococci and their bacteriophages. Appl. Microbiol. 29,
807–813.
jalsma, H., Bolhuis, A., Jongbloed, J.D., Bron, S., van Dijl, J.M.,
2000. Signal peptide-dependent protein transport inBacillus sub-
tilis: a genome-based survey of the secretome. Microbiol. Mol.
Biol. Rev. 64, 515–547.
eening, J.W., Smits, W.K., Hamoen, L.W., Jongbloed, J.D.H.,
Kuipers, O.P., 2004. Visualization of differential gene expres-
sion by improved cyan fluorescent protein and yellow fluorescentnology 127 (2007) 361–372
protein production in Bacillus subtilis. Appl. Environ. Microbiol.
70, 6809–6815.
itikainen, M., Pummi, T., Airaksinen, U., Wahlstrom, E., Wu, H.,
Sarvas, M., Kontinen, V.P., 2001. Quantitation of the capacity of
the secretion apparatus and requirement for PrsA in growth and
secretion of alpha-amylase in Bacillus subtilis. J. Bacteriol. 183,
1881–1890.
esters, H., Darmon, E., Zanen, G., Veening, J.W., Kuipers, O.P.,
Bron, S., Quax, W.J., van Dijl, J.M., 2004. The Bacillus secre-
tion stress response is an indicator for alpha-amylase production
levels. Lett. Appl. Microbiol. 39, 65–73.
u, S.C., Yeung, J.C., Duan, Y., Ye, R., Szarka, S.J., Habibi, H.R.,of a fibrin-specific single-chain antibody fragment from Bacil-
lus subtilis: effects of molecular chaperones and a wall-bound
protease on antibody fragment production. Appl. Environ. Micro-
biol. 68, 3261–3269.
